{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:06:43Z","timestamp":1768723603051,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["26220220187"],"award-info":[{"award-number":["26220220187"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-0305-12"],"award-info":[{"award-number":["APVV-0305-12"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-17-0052"],"award-info":[{"award-number":["APVV-17-0052"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0255\/18"],"award-info":[{"award-number":["1\/0255\/18"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0260\/14"],"award-info":[{"award-number":["1\/0260\/14"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0356\/18"],"award-info":[{"award-number":["1\/0356\/18"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.resp.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T14:18:09Z","timestamp":1515680289000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Inhibitors of phosphodiesterases in the treatment of cough"],"prefix":"10.1016","volume":"257","author":[{"given":"Juraj","family":"Mokry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Urbanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kertys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mokra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2018.01.008_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bcpt.12209","article-title":"Dual PDE3\/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases","volume":"114","author":"Abbott-Banner","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.resp.2018.01.008_bib0010","first-page":"412","article-title":"Roflumilast for the treatment of chronic obstructive pulmonary disease","volume":"7","author":"Antoniu","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.resp.2018.01.008_bib0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-3565(24)39017-2","article-title":"Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets","volume":"295","author":"Aoki","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-3565(24)29484-2","article-title":"Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor","volume":"298","author":"Aoki","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0025","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ptr.5610","article-title":"Dual inhibition of Ca(+2) influx and phosphodiesterase enzyme provides scientific base for the medicinal use of Chrozophora prostrata Dalz. in respiratory disordersz","volume":"30","author":"Arshad","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0030","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.pupt.2015.08.006","article-title":"Roflumilast for asthma: efficacy findings in mechanism of action studies","volume":"35","author":"Bardin","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1183\/09031936.94.07030579","article-title":"Theophylline in the management of asthma: time for reappraisal?","volume":"7","author":"Barnes","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2018.01.008_bib0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.coph.2008.03.001","article-title":"Frontrunners in novel pharmacotherapy of COPD","volume":"8","author":"Barnes","year":"2008","journal-title":"Curr. Opinion. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","article-title":"Theophylline","volume":"188","author":"Barnes","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2018.01.008_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.pupt.2015.08.001","article-title":"Roflumilast for asthma: weighing the evidence","volume":"35","author":"Bateman","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.resp.2018.01.008_bib0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.resp.2018.01.008_bib0065","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1164\/ajrccm\/145.5.1087","article-title":"Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine","volume":"145","author":"Bj\u00f6rk","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.resp.2018.01.008_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2017.06.009","article-title":"Cough and airway disease: the role of ion channels","author":"Bonvini","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Chung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0080","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jaci.2013.11.017","article-title":"Theophylline inhibits the cough reflex through a novel mechanism of action","volume":"133","author":"Dubuis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.resp.2018.01.008_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2014.07.004","article-title":"Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases","volume":"29","author":"Dupont","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2005.02.007","article-title":"The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs","volume":"513","author":"El Hashim","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pupt.2006.05.004","article-title":"Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs","volume":"20","author":"Fujimura","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2005.12.063","article-title":"The transient receptor potential vanilloid 1: role in airway inflammation and disease","volume":"533","author":"Geppetti","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coph.2014.04.001","article-title":"Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease","volume":"16","author":"Giembycz","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.5384","article-title":"Studies on bronchodilator activity of salvia officinalis (Sage): possible involvement of K+ channel activation and phosphodiesterase inhibition","author":"Gilani","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(12)60304-3","article-title":"Side-effects of roflumilast","volume":"379","author":"Gupta","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2018.01.008_bib0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-9974-1-6","article-title":"Comparison of cough reflex sensitivity after an inhaled antigen challenge between actively and passively sensitized guinea pigs","volume":"1","author":"Hara","year":"2005","journal-title":"Cough"},{"key":"10.1016\/j.resp.2018.01.008_bib0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-9974-1-11","article-title":"Phosphodiesterase 3 inhibition and cough in elderly asthmatics","volume":"1","author":"Ishiura","year":"2005","journal-title":"Cough"},{"key":"10.1016\/j.resp.2018.01.008_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4196\/kjpp.2012.16.3.211","article-title":"Activation of the cGMP\/Protein kinase G pathway by nitric oxide can decrease TRPV1 activity in cultured rat dorsal root ganglion neurons","volume":"16","author":"Jin","year":"2012","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.1E651","article-title":"The potential role of roflumilast: the new phosphodiesterase-4 inhibitor","volume":"40","author":"Karish","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.resp.2018.01.008_bib0145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.21037\/jtd.2017.03.116","article-title":"Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases","volume":"9","author":"Kawamatawong","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.resp.2018.01.008_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(05)17708-3","article-title":"Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease","volume":"365","author":"Lipworth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2018.01.008_bib0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/ecp.13.2","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations","volume":"6","author":"Louie","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0160","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/13543784.2014.921157","article-title":"PDE inhibitors currently in early clinical trials for the treatment of asthma","volume":"23","author":"Matera","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.resp.2018.01.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2017.05.011","article-title":"Bronchodilator therapy for chronic cough","author":"Matera","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.resp.2018.01.008_bib0170","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/COPD.S150887","article-title":"Doxofylline is not just another theophylline!","volume":"2017","author":"Matera","year":"2017","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"10.1016\/j.resp.2018.01.008_bib0175","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1034\/j.1399-6576.2000.440617.x","article-title":"Comparative effect of amrinone, aminophylline and diltiazem on rat airway smooth muscle","volume":"44","author":"Matsuda","year":"2000","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.resp.2018.01.008_bib0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-9974-1-2","article-title":"An overview of the sensory receptors regulating cough","volume":"1","author":"Mazzone","year":"2005","journal-title":"Cough"},{"key":"10.1016\/j.resp.2018.01.008_bib0185","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1007\/s00408-007-9032-z","article-title":"TRPV1 antagonists as potential antitussive agents","volume":"186","author":"McLeod","year":"2008","journal-title":"Lung"},{"key":"10.1016\/j.resp.2018.01.008_bib0190","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.3390\/ph9030045","article-title":"TRPV1 and TRPM8 in treatment of chronic cough","volume":"9","author":"Millqvist","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.resp.2018.01.008_bib0195","doi-asserted-by":"crossref","first-page":"13424","DOI":"10.1074\/jbc.M410917200","article-title":"Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase","volume":"280","author":"Mohapatra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.resp.2018.01.008_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.resp.2013.02.004","article-title":"Immunological aspects of phosphodiesterase inhibition in the respiratory system","volume":"187","author":"Mokry","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.resp.2018.01.008_bib0205","first-page":"131","article-title":"The influence of the PDE inhibitors on cough reflex in guinea pigs","volume":"112","author":"Mokry","year":"2011","journal-title":"Bratisl. Lek. Listy."},{"key":"10.1016\/j.resp.2018.01.008_bib0210","first-page":"473","article-title":"Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity","volume":"59","author":"Mokry","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0215","first-page":"87","article-title":"Influence of xanthine derivatives on cough and airway reactivity in guinea pigs","volume":"60","author":"Mokry","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-94-007-4549-0_8","article-title":"Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized Guinea pigs","volume":"756","author":"Mokry","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.resp.2018.01.008_bib0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/5584_2016_237","article-title":"Effects of selective inhibition of PDE4 by YM976 on airway reactivity and cough in ovalbumin-sensitized Guinea pigs","volume":"921","author":"Mokr\u00fd","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.resp.2018.01.008_bib0230","article-title":"Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in Guinea pigs","volume":"58","author":"Mokry","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0235","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1183\/09031936.00101006","article-title":"ERS guidelines on the assessment of cough","volume":"29","author":"Morice","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2018.01.008_bib0240","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.21037\/jtd.2017.06.18","article-title":"Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial","volume":"9","author":"Morice","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.resp.2018.01.008_bib0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-9974-9-14","article-title":"Chronic cough hypersensitivity syndrome","volume":"9","author":"Morice","year":"2013","journal-title":"Cough"},{"key":"10.1016\/j.resp.2018.01.008_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2017.05.004","article-title":"TRPA1 receptors in chronic cough","author":"Morice","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(03)01754-0","article-title":"Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle","volume":"470","author":"Moriuchi","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0260","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.resp.2018.01.008_bib0265","first-page":"14","article-title":"The mechanism of action of xanthine derivatives and suppression of cough","volume":"1","author":"Nosalova","year":"2001","journal-title":"Acta Med. Martiniana"},{"key":"10.1016\/j.resp.2018.01.008_bib0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2012.02.016","article-title":"Selective PDE inhibitors as novel treatments for respiratory diseases","volume":"12","author":"Page","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0280","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000368800","article-title":"Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease","volume":"165","author":"Page","year":"2014","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.resp.2018.01.008_bib0285","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2009.07.005","article-title":"Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease","volume":"30","author":"Polosa","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.resp.2018.01.008_bib0290","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.95.08040637","article-title":"Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants","volume":"8","author":"Rabe","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2018.01.008_bib0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0300","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.CIR.0000074226.20466.B1","article-title":"Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension","volume":"107","author":"Sebkhi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.resp.2018.01.008_bib0305","first-page":"A1335","volume":"195","author":"Sethi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2018.01.008_bib0310","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1590\/S0100-879X2011000600010","article-title":"Sildenafil decreases rat tracheal hyperresponsiveness to carbachol and changes canonical transient receptor potential gene expression after antigen challenge","volume":"44","author":"Sousa","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/mol.113.088997","article-title":"Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1","volume":"85","author":"Spahn","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0320","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1183\/09031936.00158208","article-title":"Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study","volume":"33","author":"Spears","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.resp.2018.01.008_bib0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/164_2016_71","article-title":"Xanthines and phosphodiesterase inhibitors","volume":"237","author":"Spina","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.resp.2018.01.008_bib0330","first-page":"24","article-title":"The role of theophylline and phosphodiesterase-4 isoenzyme inhibitors as antiinflammatory drugs","volume":"28","author":"Spina","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.resp.2018.01.008_bib0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-9974-5-6","article-title":"Cough and dyspnea during bronchoconstriction: comparison of different stimuli","volume":"5","author":"Suguikawa","year":"2009","journal-title":"Cough"},{"key":"10.1016\/j.resp.2018.01.008_bib0340","first-page":"A5717","article-title":"Combined effects of the phosphodiesterase type 4 (PDE4) inhibitor, roflumilast, and the PDE5 inhibitor, tadalafil, in allergen-induced airway hyperresponsiveness (AHR)","volume":"179","author":"Takeda","year":"2009","journal-title":"Am. J. Crit. Care Med."},{"key":"10.1016\/j.resp.2018.01.008_bib0345","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1164\/rccm.200211-1372OC","article-title":"Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease","volume":"169","author":"Toward","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2018.01.008_bib0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/5584_2016_31","article-title":"Bronchodilator and anti-inflammatory action of theophylline in a model of ovalbumin-induced allergic inflammation","volume":"935","author":"Urbanova","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.resp.2018.01.008_bib0355","doi-asserted-by":"crossref","DOI":"10.1080\/01902148.2017.1386735","article-title":"Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in Guinea pigs","author":"Urbanova","year":"2017","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fj.04-1990fje","article-title":"Theobromine inhibits sensory nerve activation and cough","volume":"19","author":"Usmani","year":"2005","journal-title":"FASEB. J."},{"key":"10.1016\/j.resp.2018.01.008_bib0365","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/COPD.S29990","article-title":"Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study","volume":"7","author":"Voduc","year":"2012","journal-title":"Int. J. Chron. Obstruct. Pulm. Dis."},{"key":"10.1016\/j.resp.2018.01.008_bib0370","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pupt.2005.09.002","article-title":"Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors","volume":"19","author":"Wollin","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.resp.2018.01.008_bib0375","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/CIRCRESAHA.107.168724","article-title":"Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4","volume":"102","author":"Yin","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.resp.2018.01.008_bib0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2011.10.007","article-title":"The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism","volume":"25","author":"van Mastbergen","year":"2012","journal-title":"Pulm. Pharmacol. Ther."}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904817303798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904817303798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:39:57Z","timestamp":1761604797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904817303798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":76,"alternative-id":["S1569904817303798"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2018.01.008","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of phosphodiesterases in the treatment of cough","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}